Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Ribosomal protein L9 pseudogene 33 (RPL9P33) is a human pseudogene that shares sequence similarity with the functional ribosomal protein L9 gene (RPL9)[4][3]. Pseudogenes such as RPL9P33 are segments of DNA that resemble known genes but are nonfunctional, usually due to mutations or lack of regulatory elements required for gene expression and protein production[5]. RPL9P33 does not code for a protein product, is not involved in ribosomal assembly, protein synthesis, or any known biological pathway, and has no direct links to disease or pharmacological targeting. Information available for RPL9P33 confirms its classification as a processed pseudogene, with no therapeutic relevance or targeting potential[4]. RPL9P33 should not be confused with RPL9 (Ribosomal protein L9), which encodes a component of the 60S large ribosomal subunit, participates in protein biosynthesis, and can be involved in disease processes such as Diamond-Blackfan anemia[7]. However, the pseudogene RPL9P33 itself has no such functions or clinical associations[4][3].
None
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Ribosomal protein L9 pseudogene 33 (RPL9P33).